Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Transplantation proceedings ; 2023.
Artículo en Inglés | EuropePMC | ID: covidwho-2249440

RESUMEN

Background Patients with hematologic malignancies are considered at high risk for COVID 19 infection either from the disease itself or from the treatment. Hematopoietic stem cell transplantation (HSCT), among one of the approved therapies for hematologic malignancies, was performed around the world during COVID 19 era with some regulations such as COVID 19 testing before proceeding with transplantation or cellular therapy. Up to authors' knowledge, none have reported the result of autologous HSCT in an active COVID 19 patient. Case Presentation We describe a successful clinical course of autologous bone marrow transplantation for two lymphoma patients tested positive for COVID 19. Thorough discussion between multidisciplinary hemato-oncology, intensive care and infectious diseases teams was done, and the decision was to proceed towards BMT with some modifications in the transplantation protocol and close monitoring for the patients. Conclusions Our cases lend credence that successful autologous BMT is possible among active COVID 19 patients and the obstacles, which we faced, could be overcome with the collaboration between a highly qualified multidisciplinary team. Despite the potential complications, the benefits of bone marrow transplantation among patients with high risk of relapse and still COVID 19 positive outweighs the risks but further studies are still recommended to support our inference.

2.
Transplant Proc ; 55(3): 543-546, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: covidwho-2249441

RESUMEN

BACKGROUND: Patients with hematologic malignancies are considered at high risk for COVID-19 infection either from the disease or the treatment. Hematopoietic stem cell transplantation, one of the approved therapies for hematologic malignancies, was performed worldwide during the COVID-19 era with some regulations, such as COVID-19 testing, before proceeding with transplantation or cellular therapy. To the authors' knowledge, none have reported the result of autologous hematopoietic stem cell transplantation in an active COVID-19 patient. CASE PRESENTATION: We describe a successful clinical course of autologous bone marrow transplantation for 2 lymphoma patients who tested positive for COVID-19. A thorough discussion was conducted between multidisciplinary hemato-oncology, intensive care, and infectious diseases teams. The decision was to proceed toward bone marrow transplantation with some modifications in the transplantation protocol and close patient monitoring. CONCLUSION: Our cases lend credence that successful autologous bone marrow transplantation is possible among active COVID-19 patients. The obstacles we faced could be overcome with collaboration between a highly qualified multidisciplinary team. Despite the potential complications, the benefits of bone marrow transplantation among patients with a high risk of relapse and who are still COVID-19-positive outweigh the risks. However, further studies are still recommended to support our inference.


Asunto(s)
COVID-19 , Neoplasias Hematológicas , Trasplante de Células Madre Hematopoyéticas , Humanos , Trasplante de Médula Ósea/efectos adversos , Prueba de COVID-19 , Recurrencia Local de Neoplasia/etiología , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Trasplante de Células Madre Hematopoyéticas/métodos , Trasplante Autólogo
3.
Cardiol Res Pract ; 2021: 6653061, 2021.
Artículo en Inglés | MEDLINE | ID: covidwho-1093885

RESUMEN

BACKGROUND: The standard electrocardiogram (ECG) is commonly performed in the supine posture. It may be difficult to report ECG in a supine posture for those who are unable to adopt the supine posture because of certain circumstances such as acute respiratory distress syndrome-patients who are placed in a prone position for long periods to improve oxygenation. Few data are available on the impact of the prone position on the ECG recording with electrodes on the posterior chest. Examining and analyzing the type and extent of changes observed in the prone ECG in healthy adults have become vitally valuable. METHODS: A cross-sectional observational study enrolled forty healthy adults (24 males and 16 females) aged between 18 and 40 years. The ECG was performed in two different body positions, supine and prone. Influence of prone position on the heart rate, mean QRS axis, amplitude, morphology, duration, mean T wave axis and polarity, mean P wave axis, PR, and mean QTc duration was evaluated. RESULTS: The mean heart rate was higher in the prone position (73.2 ± 12.4 bpm) compared with the supine position (69.5 ± 11.5 bpm, p = 0.03). The QRS duration decreased considerably from supine (92.8 ± 12.6 ms) to prone (84.9 ± 11.9 ms, p < 0.001). The mean QRS axis moved to the left in the prone posture (40.5° ± 32°) relative to the supine (49° ± 28°, p=0.015). The QRS amplitude in the precordial leads was significantly decreased from supine (7.42 ± 3.1 mV) to prone (3.68 ± 1.7 mV, p < 0.001). In addition, changes in the QRS morphology in leads V1-V3 with the appearance of new Q waves were noted. A notable variation in the mean corrected QT (QTc) period with decrease in duration in prone posture ECG (385 ± 64.8) relative to supine (406 ± 18.8, p=0.05). CONCLUSIONS: Prone position ECG resulted in significant changes in healthy adults that should be aware of this as this can affect diagnosis and management strategies. Further studies are needed to investigate the impact of prone position on ECG recording in patients with cardiovascular diseases.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA